Showing recent highlights
Medications
PubMed · December 1, 2026
This research looked at two blood thinners — Eliquis (apixaban) and Xarelto (rivaroxaban) — compared to an older blood thinner called warfarin, in people who have atrial fibrillation (an irregular heartbeat that raises stroke risk) and are on dialysis due to serious kidney disease. The study found that Eliquis and Xarelto were linked to lower rates of dangerous bleeding, stroke, and death compared to warfarin in this group, which is a meaningful safety and effectiveness update for a population that has historically been very difficult to treat. This adds to a growing picture suggesting these newer blood thinners may be a safer option than warfarin for people in this specific situation, though your doctor would weigh all the details before making any decision.
Ask your doctor: Ask the doctor whether apixaban might be safer than warfarin for preventing blood clots if the patient have atrial fibrillation and kidney problems.
What's New
PubMed · December 1, 2026
Researchers found something surprising: smartwatches and wearable heart monitors were very good at spotting atrial fibrillation — an irregular heartbeat that can raise the risk of serious heart problems like heart attacks or strokes — but finding more cases didn't actually seem to lead to better health outcomes for people screened. In fact, continuous monitoring nearly tripled the number of diagnoses and doubled the use of blood-thinning medications, yet the extra treatment didn't clearly prevent harm, raising the question of whether some of those diagnoses may not have needed treatment at all — a concept called 'overdiagnosis,' meaning the condition was detected but may never have caused problems. Someday this research might help doctors figure out who truly benefits from wearable heart screening, rather than putting more people through treatment they may not need. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether using a smartwatch or fitness tracker to check the patient's heart rhythm could lead to finding an irregular heartbeat that might not actually need treatment.
What's New
PubMed · November 1, 2026
Researchers found that a procedure called catheter ablation — where doctors use heat or cold energy to correct the faulty electrical signals causing an irregular heartbeat — may significantly reduce the risk of death and hospital stays in people who have both atrial fibrillation (an irregular heartbeat) and heart failure, compared to medication alone. The study, which combined data from 7 smaller studies and over 2,000 patients, also found that the heart's pumping strength improved more in people who had the procedure. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a small procedure called left atrial appendage closure — where a tiny device is implanted to seal off a pouch in the heart where blood clots commonly form in people with atrial fibrillation (an irregular heartbeat) — may work as well as blood-thinning medications at preventing strokes, while also reducing serious bleeding risks. This matters because some people with atrial fibrillation can't tolerate blood thinners long-term, and having a non-medication option could be important for them. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · November 1, 2026
A study found that people with atrial fibrillation (an irregular heartbeat condition) who followed a nurse-guided walking program — at least 30 minutes of walking, at least 3 days a week, for 12 weeks — reported noticeably fewer and less bothersome symptoms compared to those who didn't follow the program. Researchers also found improvements in several areas of daily life, including energy levels, social activities, emotional well-being, and physical ability. The program included weekly check-in calls from a nurse and a simple step-counting device to help people stay on track.
What's New
PubMed · November 1, 2026
Researchers found that a simple four-factor scoring tool — called the ALID score — may help identify which people with a common heart rhythm problem called atrial fibrillation (where the heart beats irregularly) are most likely to benefit from a specific type of extra heart procedure done alongside standard treatment. The scoring tool suggested that people with higher scores were more likely to see fewer episodes of irregular heartbeat after the additional procedure, while those with lower scores may actually have had more episodes return — which is a striking and somewhat unexpected finding. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that among people with atrial fibrillation — an irregular heartbeat — not everyone responds the same way to catheter ablation, a procedure that uses heat or cold energy to correct the heart's electrical signals. Specifically, older patients who had fewer additional health conditions appeared to benefit the most from ablation compared to medication alone, while other groups showed less clear differences. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a more extensive heart rhythm procedure — one that treats the heart from both the outside and inside — did not harm the heart's upper left chamber (the atrium) any more than the standard inside-only procedure. Both approaches led to meaningful improvements in how well that chamber was squeezing and functioning after six months. For people with a type of irregular heartbeat called atrial fibrillation, this is reassuring because it suggests the more thorough procedure doesn't come with an added downside of weakening that part of the heart. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a newer, size-adjustable balloon used during a heart procedure called ablation — where doctors use cold energy to correct atrial fibrillation (an irregular heartbeat) — caused more cases of phrenic nerve injury than the standard balloon. The phrenic nerve controls breathing, and when irritated during this procedure, it can temporarily affect how well a person breathes; the good news is that all affected patients fully recovered within the follow-up period. Both balloons worked about equally well at keeping the irregular heartbeat away over 12 months, so the difference mainly came down to that safety concern with the newer device. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that two different tools used to treat atrial fibrillation — an irregular heartbeat condition — worked equally well at keeping the heart rhythm stable over 12 months, with about 76–82% of patients staying free of abnormal rhythms. One tool completed the procedure much faster (around 44 minutes vs. nearly 2 hours), but the other offered more flexibility if new irregular rhythms appeared during the procedure. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a more personalized approach to a heart procedure called ablation — where doctors use electrical signal maps to guide treatment for a type of irregular heartbeat known as atrial fibrillation — led to better results than a standard technique. In the study, about 82% of patients who received the signal-guided approach were free from irregular heartbeat episodes after 12 months, compared to about 66% with the usual method. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that people with atrial fibrillation (an irregular heartbeat) who also had a leaky heart valve — a condition called mitral regurgitation, where a valve doesn't close properly — had fewer serious heart problems like heart attacks or strokes when they received catheter ablation (a procedure that uses heat or cold energy to correct abnormal electrical signals in the heart) compared to those who were treated only with medication. The study also found that those who had the procedure were less likely to die from heart-related causes or any cause at all over a follow-up period of about four years. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether catheter ablation might be a better option for the patient than just taking medications if the patient has atrial fibrillation and mitral regurgitation.
What's New
PubMed · November 1, 2026
Researchers found that during a heart rhythm procedure called cryoablation — which uses freezing to correct atrial fibrillation (an irregular heartbeat) — stimulating a key nerve through the neck was safe and effective in 92% of patients tested. This nerve, called the phrenic nerve, controls the diaphragm (the muscle that helps you breathe), and doctors need to monitor it carefully during the procedure to avoid accidentally injuring it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 28, 2026
Researchers found that combining a traditional Chinese herbal medicine called Shensong Yangxin (SSYX) with standard rhythm-control drugs after a heart procedure called catheter ablation — where doctors use energy to correct abnormal electrical signals in the heart — may significantly reduce the chances of atrial fibrillation (an irregular heartbeat) coming back. Across nine studies involving over 2,000 patients, adding SSYX appeared to cut the early return of atrial fibrillation nearly in half, and also showed benefits for patients whose irregular heartbeat had lasted longer before treatment. The researchers noted no major safety concerns with the combination, though they cautioned that most of the studies were done in non-Western populations, so it's unclear how well these results would apply more broadly. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 28, 2026
Researchers found that people with severe heart failure and an irregular heartbeat called atrial fibrillation — where the heart's upper chambers quiver instead of beating steadily — may do better when a procedure called catheter ablation is added to their usual medications. Catheter ablation uses small bursts of energy delivered through a thin tube to correct the irregular heartbeat. In this study, patients who received ablation were less likely to die, need a heart transplant, or require a mechanical heart pump compared to those on medication alone. This is early research and hasn't yet changed treatment guidelines.
What's New
NEJM · October 21, 2026
Researchers found that a technique called pulsed field ablation — which uses brief, precisely targeted bursts of electrical energy to correct the faulty signals causing an irregular heartbeat — may be effective for people with a persistent form of atrial fibrillation (a condition where the heart beats irregularly and can raise the risk of serious heart problems like heart attacks or strokes). This is notable because persistent atrial fibrillation can be harder to treat than the kind that comes and goes on its own. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 21, 2026
A study found that for people with atrial fibrillation (an irregular heartbeat that raises the risk of stroke) who had a heart stent placed at least a year earlier, taking a blood thinner alone was linked to less serious bleeding compared to taking a blood thinner combined with an additional anti-clotting medication — and this held true regardless of how long ago the stent was placed. Researchers also looked at whether the time since the stent was placed changed which approach was safer for preventing serious heart problems like heart attacks or strokes, but the results were inconsistent across different ways of analyzing the data. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 10, 2026
Researchers found that people with atrial fibrillation — an irregular heartbeat that can raise the risk of stroke — had better health outcomes when they received coordinated, all-around care using digital tools like a smartphone app or telehealth support from their doctor, compared to usual care. Specifically, this approach was linked to fewer serious events like death, strokes, heart failure, and bleeding episodes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 9, 2026
Researchers found that during a heart procedure used to treat atrial fibrillation — an irregular heartbeat — spacing the treatment points slightly farther apart (6 mm instead of the standard 4 mm) made the procedure faster and required fewer energy applications, but was less likely to successfully isolate the problem areas in the heart in one pass. Atrial fibrillation happens when the heart's upper chambers fire chaotic electrical signals, and this procedure tries to block those signals by creating a ring of small scars around certain veins. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with a type of irregular heart rhythm called persistent atrial fibrillation — where the heart stays out of its normal rhythm rather than returning on its own — progress to a more permanent form of the condition at a rate of about 16 cases per 100 people per year. Interestingly, those who had undergone a procedure called pulmonary vein isolation, where doctors use energy to block the faulty electrical signals causing the irregular rhythm, were less likely to see their condition worsen over time. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that a procedure called catheter ablation — where doctors use heat or cold energy to correct an irregular heartbeat — may help people with severe heart failure live longer, and it appears to be a cost-effective option compared to medication alone. Researchers found that patients who received this procedure alongside their usual medications gained about 1.7 extra years of life on average, at a relatively modest added cost. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with atrial fibrillation — an irregular heartbeat that can raise the risk of serious heart problems like heart attacks or strokes — may do better if they have catheter ablation sooner rather than later. Catheter ablation is a procedure that uses energy to correct the faulty electrical signals causing the irregular heartbeat. In a review of 10 studies involving more than 22,000 patients, those who had the procedure within a year of diagnosis were significantly less likely to have their irregular heartbeat return, and were also less likely to be hospitalized or need additional procedures to reset their heart rhythm. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether having catheter ablation earlier — within the first year after being diagnosed with atrial fibrillation — might give the patient a better chance of preventing the irregular heartbeats from coming back compared to waiting longer than a year to have the procedure.
What's New
PubMed · October 1, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat) who had no return of their heart rhythm problems for at least a year after a procedure called catheter ablation, stopping blood-thinning medication did not appear to cause any decline in thinking or memory skills compared to those who kept taking it. Both groups actually showed a small improvement in cognitive scores over two years. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should stop taking blood thinner medication if they haven't had atrial fibrillation come back after ablation, or whether stopping it might affect the patient's thinking and memory.
What's New
PubMed · October 1, 2026
Researchers found that people with atrial fibrillation (an irregular heartbeat) who had a return of their irregular heart rhythm within the first 90 days after a procedure called thoracoscopic ablation — where heat or cold energy is used to scar heart tissue and block faulty electrical signals — were more likely to see their irregular rhythm come back again later on, with those whose rhythm returned between 31 and 90 days after the procedure facing an even higher risk than those whose rhythm returned in the first 30 days. The study also found that certain biological changes in heart tissue, including signs of inflammation and a higher amount of proteoglycans (a type of structural protein that builds up in tissue), may help explain why some people are more likely to have their atrial fibrillation return. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat) and heart failure, a newer pacing technique called conduction system pacing — which delivers electrical signals closer to the heart's natural pathways — was linked to significantly fewer deaths compared to the more established biventricular pacing, which stimulates both lower chambers of the heart simultaneously. The analysis combined results from six studies involving 766 patients, and those who received the newer approach also showed a trend toward fewer hospital stays for heart failure, though that particular finding was just shy of being statistically definitive. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat), adding an extra step to a common heart procedure called ablation — specifically, targeting a blood vessel near the heart called the superior vena cava — reduced the chances of the irregular rhythm coming back, especially when that extra step was done routinely rather than only in certain situations. This could matter because returning irregular heartbeats after ablation are a common frustration for patients and their doctors. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that people with atrial fibrillation (an irregular heartbeat condition) who had a procedure called ablation — where doctors use heat or cold to correct the heart's electrical signals — recovered faster when a special wound-sealing device was used to close the small puncture site in the groin, compared to traditional manual pressure, cutting the time it took to stop bleeding by about 5 and a half minutes on average. This might matter because a quicker recovery at the puncture site could mean a more comfortable experience after the procedure, though the overall time until patients went home didn't appear to differ between the two approaches. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 30, 2026
Researchers found that two different imaging tools used to guide a heart procedure called ablation — which is used to treat atrial fibrillation (an irregular heartbeat) — appear to be similarly safe. One tool, used from inside the heart, was linked to shorter procedure times and less radiation exposure, but it was also less likely to detect dangerous blood clots in a part of the heart called the left atrial appendage, which could be an important consideration for patient safety. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · September 27, 2026
A study found that a type of blood thinner called a direct oral anticoagulant — a medication that helps prevent blood clots — was linked to a much lower chance of serious complications in people with atrial fibrillation (an irregular heartbeat) who were at a medium level of risk for stroke. Specifically, researchers found fewer strokes without a rise in serious bleeding, which is an important balance doctors look for when weighing this type of treatment. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 24, 2026
Researchers found that people with atrial fibrillation (an irregular heartbeat that can raise stroke risk) who were considered at intermediate stroke risk had significantly fewer serious outcomes — including strokes and death from heart-related causes — when they took a blood-thinning medication compared to those who took none, with about 1.5% of the untreated group experiencing these events versus only 0.5% in the treated group over two years. Atrial fibrillation can cause blood to pool and clot in the heart, and these clots can travel to the brain and cause a stroke, so finding the right patients who benefit from blood thinners is an important question. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should take a direct oral anticoagulant like apixaban or rivaroxaban to prevent stroke, even though the patient's stroke risk score is in the intermediate range.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.